47 results
8-K
EX-99.1
OVID
Ovid Therapeutics Inc
2 Oct 23
Dawn of the neurotherapeutics era Dr. Jeremy Levin CEO & Chairman
12:15pm
Extracellular Neuronal Environment Physiological homeostasis Optimal efficacy, safety & tolerability Pathologic Conditions: Epilepsy Pain … Excitability Extracellular Neuronal Environment
Ovid strategy: Unique mechanisms to achieve neuronal balance (homeostasis) Physiological homeostasis
8-K
EX-1.1
14st0e9w9p8h1m
26 Aug 20
Ovid Therapeutics Announces Pricing of $50 Million Offering of Common Stock
4:10pm
424B5
dfx8yb5wx31m
26 Aug 20
Prospectus supplement for primary offering
4:07pm